Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Fortis Frontier PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. The company offers general health and energy profile blood test, bowel health rapid test, and stomach ulcer rapid test; nutritional health tests, such as intolerances and sensitivities DNA tests, vitamins and minerals DNA and profile blood tests, iron deficiency rapid test, and vitamin D rapid test; and weight management tests that includes weight management DNA and blood tests, glucose management DNA tests, and thyroid profile blood test and stimulating hormone rapid test. It also provides cardiovascular health tests, such as heart profile blood and heart profile test; women's health tests comprising female sexual health test, polycystic ovary syndrome blood test, and menopause profile blood test; and men's health products, including erectile dysfunction blood test, male sexual health test, and sperm concentration rapid test. The company was formerly known as MyHealthChecked PLC and changed its name to Fortis Frontier PLC in November 2025. Fortis Frontier PLC was incorporated in 2008 and is based in Cardiff, the United Kingdom.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is undervalued on EV/EBITDA, underpriced on P/FC.